Production (Stage)
Proto Script Pharmaceutical Corp.
PSCR
$0.0003
$0.000.00%
OTC PK
| 09/30/2017 | 06/30/2017 | 03/31/2017 | 12/31/2016 | 09/30/2016 | |
|---|---|---|---|---|---|
| Net Income | -66,658.73% | -17,826.11% | -74,041.51% | -4,846.83% | -- |
| Total Depreciation and Amortization | -52.57% | -81.04% | -89.33% | -93.27% | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 13,538.65% | 13,354.42% | 13,413.27% | 13,101.92% | -- |
| Change in Net Operating Assets | 943.33% | 10,887.27% | 829.35% | 541.73% | -- |
| Cash from Operations | -151,450.00% | -750.92% | -548.98% | 15.71% | -- |
| Capital Expenditure | -492.98% | -670.21% | -347.27% | -149.18% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -492.98% | -670.21% | -347.27% | -149.18% | -- |
| Total Debt Issued | 279.38% | 739.90% | 591.12% | -30.47% | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | 100.00% | 71.56% | 34.04% | -- |
| Cash from Financing | 2,706.78% | 917.48% | 752.02% | 36.41% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -198.31% | -689.29% | 4,437.50% | 75.00% | -- |